de Waal, Luc
Lewis, Timothy A
Rees, Matthew G
Tsherniak, Aviad http://orcid.org/0000-0002-3797-1877
Wu, Xiaoyun
Choi, Peter S
Gechijian, Lara
Hartigan, Christina
Faloon, Patrick W
Hickey, Mark J
Tolliday, Nicola
Carr, Steven A
Clemons, Paul A
Munoz, Benito
Wagner, Bridget K
Shamji, Alykhan F
Koehler, Angela N
Schenone, Monica
Burgin, Alex B
Schreiber, Stuart L http://orcid.org/0000-0003-1922-7558
Greulich, Heidi
Meyerson, Matthew
Article History
Received: 19 March 2015
Accepted: 28 October 2015
First Online: 14 December 2015
Change Date: 22 December 2015
Change Type: Erratum
Change Details: In the version of this article initially published, there was a typographical error in the Additional Information section that switched H.G. to H.H. The error has been corrected in the print, HTML and PDF versions of the article.
Competing interests
: L.d.W., T.A.L., X.W., P.A.C., S.L.S., H.G. and M.M. receive research support from Bayer. M.M. is a founder, consultant and equity holder in Foundation Medicine. L.d.W., T.A.L., L.G., B.M., H.G. and M.M. are inventors on patent WO 2014/164704 A2, covering the chemical space around DNMDP and some of the analogs described in the supplementary information.